EYPT icon

EyePoint Pharmaceuticals
EYPT

Overview Fund Activity

50 hedge funds and large institutions have $31.4M invested in EyePoint Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 17 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
50
Holders Change
-2
Holders Change %
-3.85%
% of All Funds
1.01%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
8
Reduced
17
Closed
7
Calls
$3K
Puts
–
Net Calls
+$3K
Net Calls Change
+$12K

Top Buyers

1
Citadel Advisors
Citadel Advisors
Florida
$91K
2
GCP
GSA Capital Partners
United Kingdom
$66K
3
WS
Wedbush Securities
California
$42K
4
VF
Virtu Financial
New York
$30K
5
UBS Group
UBS Group
Switzerland
$72K

Top Sellers

1
Jane Street
Jane Street
New York
$48K
2
PP
Paloma Partners
Connecticut
$0
3
Millennium Management
Millennium Management
New York
$0
4
Vanguard Group
Vanguard Group
Pennsylvania
$1.67M
5
NAM
Nexpoint Asset Management
Texas
$18K
Name Holding Trade Value Shares
Change 		Shares
Change %
PCM
51
Prelude Capital Management
New York
– -$4K -494 Closed
Deutsche Bank
52
Deutsche Bank
Germany
– -$1K -190 Closed
1 2
3